Cerity Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Sell
9,669
-3,776
-28% -$194K ﹤0.01% 2490
2026
Q1
$797K Buy
13,445
+5,249
+64% +$341K ﹤0.01% 1985
2025
Q4
$506K Buy
8,196
+4,054
+98% +$248K ﹤0.01% 2103
2025
Q3
$258K Buy
4,142
+258
+7% +$18K ﹤0.01% 2378
2025
Q2
$310K Buy
3,884
+218
+6% +$18.2K ﹤0.01% 2139
2025
Q1
$315K Buy
3,666
+132
+4% +$10.8K ﹤0.01% 1996
2024
Q4
$256K Sell
3,534
-2,813
-44% -$218K ﹤0.01% 2112
2024
Q3
$458K Buy
6,347
+3,234
+104% +$229K ﹤0.01% 1821
2024
Q2
$214K Sell
3,113
-2,892
-48% -$196K ﹤0.01% 1999
2024
Q1
$436K Buy
+6,005
New +$402K ﹤0.01% 1664

Other funds holding PBH

Cerity Partners's PBH Position: Q2 2026 in Review

Cerity Partners reduced its Prestige Consumer Healthcare (PBH) stake by 28% in Q2 2026, selling an estimated $194K and leaving 9,669 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Cerity Partners first reported a position in PBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $797K in Q1 2026. 305 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Cerity Partners held 9,669 shares of Prestige Consumer Healthcare worth $457K as of Q2 2026.
  • Cerity Partners sold 3,776 Prestige Consumer Healthcare shares in Q2 2026, an estimated $194K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2490 holding.
  • Cerity Partners first reported a position in Prestige Consumer Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Cerity Partners's Prestige Consumer Healthcare position peaked at $797K in Q1 2026.
  • 305 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.